About Araris Biotech
Araris Biotech AG is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich pioneering a novel antibody-drug conjugate (ADC)-linker technology. Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
Facts about Araris Biotech
Facts about Araris Biotech
- Founding: 2019
- Focus : Service
- Industry : Biotechnology, Pharma
